NCT00918463 A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Status TERMINATED Phase PHASE2
NCT00918385 Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT00914641 Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00909766 Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT00909402 A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas Status COMPLETED Phase PHASE1
NCT00908752 Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC Status COMPLETED Phase PHASE3
NCT00908271 Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00908024 Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT00904176 Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00903006 Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00901498 Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00900783 A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster Status COMPLETED Phase PHASE2
NCT00898716 Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan Status COMPLETED Phase PHASE1
NCT00895960 Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma Status TERMINATED Phase PHASE1
NCT00895297 Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia Status TERMINATED Phase PHASE2
NCT00890890 A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT00886795 Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy Status COMPLETED Phase PHASE1/PHASE2
NCT00886782 A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors Status TERMINATED Phase PHASE1/PHASE2